22Z1:FRA
Zealand Pharma A S American Depository Receipt
€8.05
arrow_upward
+2.55%(+0.20) 1D
Sep 3, 3:25:01 PM GMT+2 · EUR
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 22Z1...
Open
€7.70
High
€8.05
Low
€7.70
Mkt. cap
21.62B
Volume
0.00
52-wk high
€13.90
52-wk low
€6.00
No. of employees
578
Open
€7.70
High
€8.05
Low
€7.70
Mkt. cap
21.62B
Volume
0.00
52-wk high
€13.90
52-wk low
€6.00
No. of employees
578
News stories
From web sources and news partners
Yahoo Finance UK
·
1 day ago
Correction: Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Yahoo Finance
·
3 days ago
Zealand Pharma - Transactions related to share buy-back program (week 35, 2026)
Profile
Zealand Pharma A/S is a Danish biotechnology research company, which designs and develops peptide-based medicines, mainly focusing on metabolic diseases like diabetes and obesity. The company's head office is situated in Søborg near Copenhagen, and it has close to 200 employees. In 2018, they opened a subsidiary in the US. Zealand Pharma forms part of the Danish-Swedish life science cluster Medicon Valley. Wikipedia
About Zealand Pharma A S American Depository Receipt
CEOAdam Steensberg
Employees578
FoundedApr 1, 1997
Headquarters-
SectorBiotechnology
Websitezealandpharma.com